Skip to main content
Top
Published in: Abdominal Radiology 8/2021

01-08-2021 | Hepatocellular Carcinoma | Special Section : HCC Treatment

Role of the radiologist at HCC multidisciplinary conference and use of the LR-TR algorithm for improving workflow

Authors: Anuradha S. Shenoy-Bhangle, Leo L. Tsai, Mark Masciocchi, Sandeep Singh Arora, Ania Z. Kielar

Published in: Abdominal Radiology | Issue 8/2021

Login to get access

Abstract

Multidisciplinary conferences (MDCs) play a major role in management and care of oncology patients. Hepatocellular carcinoma (HCC) is a complex disease benefiting from multidisciplinary discussions to determine optimal patient management. A multitude of liver-directed locoregional therapies have emerged allowing for more options for treatment of HCC. A radiologist dedicated to HCC-MDC is an important member of the team contributing to patient care in multiple ways. The radiologist plays a key role in image interpretation guiding initial therapy discussions as well as interpreting post-treatment imaging following liver-directed therapy. Standardization of image interpretation can lead to more consistent treatment received by the patient as well as accurate assessment of transplant eligibility. The radiologist can facilitate this process using structured reporting that is also supported by stakeholders involved in interdisciplinary management of liver diseases. The Liver Imaging Reporting and Data System (LI-RADS), is a living document which offers a standardized reporting algorithm for consistent communication of radiologic findings for HCC screening and characterization of liver observations in patients at risk for HCC. The LI-RADS post-treatment algorithm (LR-TR algorithm) has been developed to standardize liver observations following liver-directed locoregional therapy. This review article focuses on the role of the radiologist at HCC-MDC and implementation of the LR-TR algorithm for improving workflow.
Literature
2.
go back to reference Gadsden MM, Kaplan DE. Multidisciplinary Approach to HCC Management: How Can This Be Done? Dig Dis Sci. 2019;64(4):968-975 Gadsden MM, Kaplan DE. Multidisciplinary Approach to HCC Management: How Can This Be Done? Dig Dis Sci. 2019;64(4):968-975
3.
go back to reference Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Steward L, et al. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival. HPB (Oxford). 2008; 10:405-11 Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Steward L, et al. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival. HPB (Oxford). 2008; 10:405-11
4.
go back to reference Yopp AC, Mansour JC, Beg MS, et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol. 2014;21(4):1287-1295. Yopp AC, Mansour JC, Beg MS, et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol. 2014;21(4):1287-1295.
5.
go back to reference Sinn DH, Choi GS, Park HC, Kim JM, Kim H, et al. (2019) Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients. PLOS ONE 14(1): e0210730. Sinn DH, Choi GS, Park HC, Kim JM, Kim H, et al. (2019) Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients. PLOS ONE 14(1): e0210730.
6.
go back to reference Charriere, B.; Muscari, F.; Maulat, C.; Bournet, B.; Bonnet, D.; Bureau, C.; Otal, P.; Peron, J.M.; Suc, B. Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings. J. Surg. Oncol. 2017, 115, 330–336. Charriere, B.; Muscari, F.; Maulat, C.; Bournet, B.; Bonnet, D.; Bureau, C.; Otal, P.; Peron, J.M.; Suc, B. Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings. J. Surg. Oncol. 2017, 115, 330–336.
7.
go back to reference Elsayes KM, Hooker JC, Agrons MM, et al. (2017) 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiographics. 37(7):1994–2017CrossRef Elsayes KM, Hooker JC, Agrons MM, et al. (2017) 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiographics. 37(7):1994–2017CrossRef
9.
go back to reference Elsayes KM, Kielar AZ, Chernyak V, et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019; 6:49–69. Elsayes KM, Kielar AZ, Chernyak V, et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019; 6:49–69.
11.
go back to reference Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816–830. Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816–830.
12.
go back to reference Kielar A, Fowler KJ, Lewis S, et al. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). 2018;43(1):218–230. Kielar A, Fowler KJ, Lewis S, et al. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). 2018;43(1):218–230.
16.
go back to reference Flusberg M, Ganeles J, Ekinci T, Goldberg-Stein S, Paroder V, Kobi M, Chernyak V. Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis. J Am Coll Radiol. 2017 Sep;14(9):1206-1211. https://doi.org/10.1016/j.jacr.2017.02.050. Epub 2017 May 6. PMID: 28483546. Flusberg M, Ganeles J, Ekinci T, Goldberg-Stein S, Paroder V, Kobi M, Chernyak V. Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis. J Am Coll Radiol. 2017 Sep;14(9):1206-1211. https://​doi.​org/​10.​1016/​j.​jacr.​2017.​02.​050. Epub 2017 May 6. PMID: 28483546.
17.
go back to reference Poullos PD, Tseng JJ, Melcher ML, Concepcion W, Loening AM, Rosenberg J, Willmann JK. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant. AJR Am J Roentgenol. 2018 Apr;210(4):766-774. https://doi.org/10.2214/ajr.17.18725. Epub 2018 Feb 22. PMID: 29470153. Poullos PD, Tseng JJ, Melcher ML, Concepcion W, Loening AM, Rosenberg J, Willmann JK. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant. AJR Am J Roentgenol. 2018 Apr;210(4):766-774. https://​doi.​org/​10.​2214/​ajr.​17.​18725. Epub 2018 Feb 22. PMID: 29470153.
20.
go back to reference Covey AM and Hussain SM. Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. AJR Am J Roentgenol 2017 209:1, 67-76 Covey AM and Hussain SM. Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. AJR Am J Roentgenol 2017 209:1, 67-76
21.
go back to reference Shi W, He Y, Ding W, et al. (1064) Contrast-enhanced ultra- sonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta- analysis. Br J Radiol 2016(89):20150973 Shi W, He Y, Ding W, et al. (1064) Contrast-enhanced ultra- sonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta- analysis. Br J Radiol 2016(89):20150973
22.
go back to reference Hunt SJ, et al. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation. J Vasc Interv Radiol. 2009; 20(1):30–8. [PubMed: 19028117] Hunt SJ, et al. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation. J Vasc Interv Radiol. 2009; 20(1):30–8. [PubMed: 19028117]
23.
go back to reference Ehman EC, et al. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016; 41(11):2161–2168. [PubMed: 27484789] Ehman EC, et al. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016; 41(11):2161–2168. [PubMed: 27484789]
26.
go back to reference Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB. The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. Radiology. 2020 Feb;294(2):320-326. https://doi.org/10.1148/radiol.2019191581. Epub 2019 Dec 17. PMID: 31845843. Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB. The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. Radiology. 2020 Feb;294(2):320-326. https://​doi.​org/​10.​1148/​radiol.​2019191581. Epub 2019 Dec 17. PMID: 31845843.
27.
go back to reference Yun Zhang, Jinju Wang, Hui Li, Tianying Zheng, Hanyu Jiang, Mou Li, Bin Song. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Ann Transl Med. 2020 Mar;8(6):388. https://doi.org/10.21037/atm.2020.03.120. Yun Zhang, Jinju Wang, Hui Li, Tianying Zheng, Hanyu Jiang, Mou Li, Bin Song. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Ann Transl Med. 2020 Mar;8(6):388. https://​doi.​org/​10.​21037/​atm.​2020.​03.​120.
Metadata
Title
Role of the radiologist at HCC multidisciplinary conference and use of the LR-TR algorithm for improving workflow
Authors
Anuradha S. Shenoy-Bhangle
Leo L. Tsai
Mark Masciocchi
Sandeep Singh Arora
Ania Z. Kielar
Publication date
01-08-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03094-9

Other articles of this Issue 8/2021

Abdominal Radiology 8/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.